Clinical Trials
6 trialsNCT03737981 2026-05-01
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00877214 2024-08-22
MAINTAIN
University of Giessen
Phase 3 Active not recruiting
NCT02063685 2022-06-21
Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma
Fondazione Italiana Linfomi - ETS
Phase 3 Completed
NCT01039376 2019-07-30
PROLONG
Novartis
Phase 3 Terminated
NCT00921414 2018-04-27
Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
French Innovative Leukemia Organisation
Phase 3 Completed
NCT03016000 2017-07-28
Thalidomide Maintenance Treatment in DLBCL
Nanfang Hospital, Southern Medical University
Phase 3 Unknown